Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergi

Discussion Board › Forums › New Developments › Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergi

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • April 20, 2013 at 12:43 pm #70946
    gavin
    Moderator

    Glad to be of help rain!

    April 19, 2013 at 4:49 am #70945
    rain
    Member

    thanks so much Gavin – very intyeresting!

    April 17, 2013 at 7:17 pm #8241
    gavin
    Moderator

    Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.

    http://www.ncbi.nlm.nih.gov/pubmed/23588885

  • Author
    Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • The forum ‘New Developments’ is closed to new topics and replies.